oseltamivir has been researched along with Dyspnea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Firouzabadi, FD; Firouzabadi, MD; Ghalehbaghi, B; Goudarzi, S; Jahandideh, H; Roomiani, M | 1 |
| Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M | 1 |
| Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L | 1 |
| Bueti, J; Komenda, P; Reslerova, M; Rigatto, C; Sood, MM; Wiebe, C | 1 |
| Eun, BW; Hong, JY; Kang, JH; Kim, JH; Kim, KH; Ko, JH; Oh, SH | 1 |
| Cho, HJ; Cho, YK; Choi, YD; Han, DK; Kim, S; Ma, JS; Yang, ES | 1 |
1 review(s) available for oseltamivir and Dyspnea
| Article | Year |
|---|---|
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever; Humans; Hydroxychloroquine; Levetiracetam; Male; Middle Aged; Myalgia; Opsoclonus-Myoclonus Syndrome; Oseltamivir; SARS-CoV-2; Valproic Acid | 2021 |
5 other study(ies) available for oseltamivir and Dyspnea
| Article | Year |
|---|---|
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diarrhea; Dyspnea; Female; Fever; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Symptom Assessment; Young Adult | 2020 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations; Dyspnea; Fatigue Syndrome, Chronic; Female; Fever; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Oseltamivir; Research Design; Ritonavir; SARS-CoV-2; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Survivors | 2021 |
Atypical clinical presentation of H1N1 influenza in a dialysis patient.
Topics: Adult; Antiviral Agents; Critical Care; Diagnosis, Differential; Dyspnea; Emergency Treatment; Glomerulosclerosis, Focal Segmental; Hemoptysis; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Failure, Chronic; Male; Oseltamivir; Renal Dialysis | 2009 |
Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): a multicenter study in Korea.
Topics: Adolescent; Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Critical Illness; Dyspnea; Female; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lymphopenia; Male; Oseltamivir; Pandemics; Republic of Korea; Retrospective Studies | 2012 |
Recurrent plastic bronchitis in a child with 2009 influenza A (H1N1) and influenza B virus infection.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Antiviral Agents; Bronchitis; Bronchoscopy; Child; DNA, Viral; Dyspnea; Humans; Hypersensitivity; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Male; Oseltamivir; Pulmonary Atelectasis; Real-Time Polymerase Chain Reaction; Tachypnea; Tomography, X-Ray Computed | 2012 |